SpineSmith Funding: How Much Did They Raise & Key Investors

How Much Did SpineSmith Raise?
Funding & Key Investors

SpineSmith, a biotech innovator specializing in biologically integrated medical implants, has secured $350K in total capital, with its most recent funding round bringing in $350K. This major strategic investment underscores the company's advanced approach to spinal pathology treatment through innovative manufacturing and biomaterials science.

What is SpineSmith?

SpineSmith

Manufacturing

Medical Devices & Equipment

Business Services

SpineSmith is a biotechnology firm dedicated to the design and development of medical implants engineered for superior biological integration. Leveraging cutting-edge manufacturing techniques, including 3D printing and nanotechnology, alongside advanced biomaterials science, the company creates sophisticated systems for addressing spinal conditions. Their product portfolio is designed to meet the critical needs of physicians seeking effective delivery systems for biological products, ensuring optimal functionality within the human body.

How much funding has SpineSmith raised?

SpineSmith has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in SpineSmith

PPP

Public-Private Partnership

What's next for SpineSmith?

The company's substantial late-stage funding indicates a strong market position and readiness for significant scaling. This capital infusion is likely to accelerate product development, expand manufacturing capabilities, and broaden market penetration. SpineSmith's focus on biological integration and advanced technologies positions it for continued growth and leadership in the competitive medical implant sector.

See full SpineSmith company page

See More Financial Insights